American Pharmacy Blog

Obesity appears to increase risk of mortality tied to sleeping pills

admin — Sat, 17 Mar 2012 09:49:52 +0000

Obesity appears to significantly increase the risk of death tied to sleeping pills, nearly doubling the rate of mortality even among those prescribed 18 or fewer pills in a year, researchers reported Friday.

See more here:
Obesity appears to increase risk of mortality tied to sleeping pills

Sleep specialists offer advice on why Daylight Saving Time can be hazardous to health

admin — Tue, 06 Mar 2012 11:23:10 +0000

It’s National Sleep Awareness Week, and Loyola University Health System sleep specialists are offering advice on — Why Daylight Saving Time, which begins Sunday, March 11, can be hazardous to your health.

Excerpt from:
Sleep specialists offer advice on why Daylight Saving Time can be hazardous to health

Sleeping pills may increase risk of cancer-related death

admin — Tue, 28 Feb 2012 10:58:34 +0000

People are relying on sleeping pills more than ever to get a good night’s rest, but a new study by Scripps Clinic researchers links the medications to a 4.6 times higher risk of death and a significant increase in cancer cases among regular pill users.

See original here:
Sleeping pills may increase risk of cancer-related death

Viewpoints: Medicare mudslinging, ‘pound-foolish’ doc fix and unrealistic death attitudes

admin — Wed, 22 Feb 2012 13:57:56 +0000

For all its technological sophistication and hefty price tag, modern medicine may be doing more to complicate the end of life than to prolong or improve it.

Link:
Viewpoints: Medicare mudslinging, ‘pound-foolish’ doc fix and unrealistic death attitudes

Some answers about prescription psychiatric drugs

admin — Mon, 20 Feb 2012 19:37:40 +0000

The circumstances of Whitney Houston’s demise have dominated headlines and search trends since news outlets first reported of her death. Her struggle with addiction was covered extensively by the media, and even discussed candidly by Houston herself during several high-profile interviews.

Read the original here:
Some answers about prescription psychiatric drugs

Longer looks: Romney and abortion politics

admin — Fri, 09 Dec 2011 13:22:49 +0000

The heart attacks never came. Four days later, Chris woke up. It was not the awakening of Hollywood movies in which the patient comes to, just as he was, speaking full sentences and completely mobile.

Go here to see the original:
Longer looks: Romney and abortion politics

Transcept receives FDA approval for Intermezzo to treat insomnia

admin — Thu, 24 Nov 2011 09:41:56 +0000

The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep.

More:
Transcept receives FDA approval for Intermezzo to treat insomnia

Quick injection of cortisone can prevent PTSD

admin — Tue, 04 Oct 2011 10:13:00 +0000

As soldiers return home from tours in Afghanistan and Iraq, America must cope with the toll that war takes on mental health. But the treatment of Post Traumatic Stress Disorder (PTSD) is becoming increasingly expensive, and promises to escalate as yet another generation of veterans tries to heal its psychological wounds.

Visit link:
Quick injection of cortisone can prevent PTSD

Adcetris May Cost $4,500 Per Vial, Or Over $100,000 For A Course Of Lymphoma Treatment

admin — Tue, 23 Aug 2011 02:00:00 +0000

Adcetris (brentuximab vedotin), recently FDA approved for Hodgkin lymphoma and systemic anaplastic large cell lymphoma, may cost over $100,000 for a course of treatment, or $4,500 per vial. According to marketers and manufacturers, Seattle Genetics, patients typically need three vials in one dose, and from seven to nine doses per course of treatment – a cost range of from $94,500 to $121,500…

View original post here:
Adcetris May Cost $4,500 Per Vial, Or Over $100,000 For A Course Of Lymphoma Treatment

Regeneron Announces Clinical Presentations At ASRS 2011 Annual Meeting

admin — Thu, 18 Aug 2011 14:00:00 +0000

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that clinical data from four separate clinical studies of EYLEA™ (aflibercept injection) will be presented at the upcoming American Society of Retina Specialists (ASRS) meeting on Sunday, August 21 and Monday, August 22, 2011 in Boston, Massachusetts…

Go here to see the original:
Regeneron Announces Clinical Presentations At ASRS 2011 Annual Meeting